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Introduction
The hallmark of severe necrotizing acute pancreatitis
(AP), in addition to local lesions, is multi-organ involve-
ment. Extremely high mortality was observed when pan-
creatic encephalopathy developed [1]. This serious con-
dition, in recent years increasingly described in litera-
ture, occurs with neuropsychiatric signs in the early
course (usually within two weeks) of severe AP [2,3]. It
can be suspected on the basis of clinical findings but the
final diagnosis is generally provided by post mortem
examination [4]. The prevalence of encephalopathy dur-
ing AP was reported from 2% [5] to 35% in one of
prospective studies analyzing electroencephalographic
and CSF changes [6]. In a recent study pancreatic
encephalopathy was diagnosed in 18.2% of patients with
severe AP [2]. The patomechanism of the condition is
unclear and there is no specific treatment [3].
We observed previously an increase in systemic
quinolinic acid (QUIN) concentration during experimen-
tal edematous acute pancreatitis [7]. QUIN is 
a product of tryptophan (TRP) metabolism via the
kynurenine (KYN) pathway (Fig. 1). QUIN is an
endogenous specific agonist of excitatory N-methyl-D-
aspartate (NMDA) receptor. In excess QUIN causes
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Abstract: Pancreatic encephalopathy is a serious, often lethal complication of acute pancreatitis (AP). Its pathomechanism
remains obscure. We have previously described increased blood levels of quinolinic acid (QUIN) – an endogeneous neuro-
toxine – during edematous experimental acute pancreatitis. Several other metabolites of tryptophan (TRP) are also known
to be neuroactive. The aim of the present study was to assess tryptophan and its main metabolites: kynurenine (KYN), 
3-hydroxykynurenine, quinolinic acid (QUIN), kynurenic acid (KYNA), serotonin (5HT) during experimental acute necro-
tizing acute pancreatitis. Experimental necrotizing acute pancreatitis was induced in rats by intraductal injection of 5% sodi-
um taurocholate. Control groups consisted of sham-operated and not operated rats. The animals were sacrificed 5 and 
24 hours after the operation. We evaluated  -amylase, pancreas weight and histology as parameters of pancreatitis. A sim-
plified neurological scoring system was applied. To assess TRP and its metabolites in plasma, we used high performance
liquid chromatography. Five hours after the onset of AP we found significant increase in TRP metabolites: QUIN, KYNA,
KYN, and 3HKYN in the plasma of animals with AP, as compared to the control group. When assessed 24 hours after induc-
tion of AP, those changes were no longer observed in blood. Instead, a decrease in TRP level appeared. Increase in plasma
QUIN was associated with neurologic disturbances. In the present study we demonstrated transient activation of kynurenine
pathway during early stages of experimental necrotizing AP, with increased blood levels of QUIN, KYNA, KYN, and
3HKYN and subsequent depletion of TRP.  As some kynurenine derivatives, e.g. quinolinic acid, are endogenous toxins,
they might contribute to neurologic and other organs disturbances during AP. 
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seizures, as was demonstrated in animals [8]. QUIN was
also shown to be implicated in hepatic and AIDS-related
encephalopathy. In patients dying of hepatic coma, the
concentrations of QUIN in the frontal cortex were found
to be 2- to 3 times greater than in samples taken from
control subjects [8]. 
Several other metabolites of tryptophan (TRP) are
also known to be neuroactive: 3-hydroxykynurenine,
kynurenic acid (KYNA), serotonin (5HT) [9-11].
Interestingly, while 3HKYN and QUIN were
described for their neurotoxic properties, KYNA and
5HT have neuroprotective potential. To our knowledge
there have been no reports on above-mentioned
metabolites in acute pancreatits.
The aim of the present study was to assess tryptophan
and its main metabolites during acute necrotizing acute
pancreatitis. Our interest in the subject is supported by
the availability of therapeutic agents counteracting the
toxicity of QUIN and other tryptophan metabolites [8].
Materials and methods
Animal model. All experiments were conducted with the prior
approval of the Local Ethical Committee and according to interna-
tional guidelines. Male Wistar rats weighing about 200g were used.
They received standard chow and water ad libitum and were kept
at the temperature of 21°C with a 12 h dark-light cycle. The ani-
mals were deprived of food starting 12 hours before the experi-
ment, but had free access to water.
Necrotizing AP was induced according to Aho et al. [12]. After
peritoneal anesthesia with sodium pentobarbital 40mg/kg, a mid-
line laparotomy was performed. The biliopancreatic duct was can-
nulated transduodenally with a blunt injection needle at a depth of
5 mm. The hepatic duct at the hilum of the liver was closed with 
a small bulldog clamp and a 2-0 silk ligature was tightened around
the needle and the wall of the duct. A 5% sodium taurocholate (0.1
ml/100g) in saline was injected under a steady manual pressure
over a period of 60 sec. After removal of the needle and the liga-
ture, the incision was closed in two layers using 8-0 Vicryl sutures.
The abdomen was closed in two layers and 4 ml saline was inject-
ed in the back subcutaneously.
After the operation the animals were observed for neurological
deficits. We used a simplified scoring system, based on the work of
Garcia et al. [13] (Table 2).
Experimental animals were sacrificed at 5 or 24 hours after the
operation (Table 1). Blood was taken from the right ventricle under
peritoneal anesthesia with sodium pentobarbital 40 mg/kg. 7.2 ml
of blood was poured into a tube containing 0.8 ml of 3.8% sodium
citrate. Immediately after sampling, the blood was centrifuged at
3.500 rpm for 10 minutes at 4°C. Plasma was separated and stored
at -70°C until it was assayed.
Tissue samples of pancreas head were fixed in formaldehyde
for subsequent paraffin embedding and staining. A portion of pan-
creas was taken for wet/dry ratio assessment (as described below).
Experimental design. Rats were randomly allocated to five groups
according to Table 1. Control animals were not operated on. In both
groups with acute pancreatitis, the disease was induced as described
above. After 5 or 24 hours the animals were sacrificed. Sham-oper-
ated rats were laparotomized in the medline. The biliopancreatic
duct was cannulated transduodenally with a blunt injection needle at
a depth of 5 mm. A 2-0 silk ligature was tightened around the needle
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Table 1. Study design: groups specification, surgical procedures, time of sacrifice and number of animals. In the bottom pannel we show
the results of amylase concentration in plasma (mean   SD), wet/dry ratio of pancreata (mean ± SD) and neurological score (median (full
range)). Significant differences as compared to the control group are shown as: * – p<0.05; ** – p<0.01; *** – p<0.001; as compared to
sham operated animals: # – p<0.05; # # # – p<0.001. AP – acute pancreatitis; ST – sodium taurocholate (5%)
Table 2. The neurological evaluation system. Based on [13], modified.
Fig. 1. The simplified scheme of kynurenine pathway (enzymes
included). 
and the wall of the duct, but no injection was performed. After 
1 minute a needle was withdrawn and both intestine and abdominal
wall were closed in two layers. The time of sacrifice of sham-oper-
ated animals was either 5 or 24 hours.
Amylase. Plasma amylase activity was measured using a quantita-
tive colorimetric assay (Phadebas Amylase Test, Pharmacia 
& Upjohn, Sweden).
HPLC determination of TRP and its metabolites. Prior to analy-
sis, the plasma was deproteinized with 2 M trichloroacetic acid,
and after centrifugation at 14.000 rpm for 10 minutes (temp. 4°C),
supernatant was filtered through a filter (WATERS 0.45 μm).
TRP, KYNA and anthranilic acid (AA) were assessed according
to the method described by Herve et al. [14]. The reverse-phase sys-
tem was composed of a Waters Spherisorb S3 ODS2 150 × 2.1 mm
column (USA), HP 1050 pump (Germany) and Rheodyne injection
valve. The effluent was monitored using a fluorescence detector HP
1046A (Germany). Excitation and emission wavelengths were set at
254/404 nm for TRP and KYNA and for 320/420 nm for AA. The
mobile phase was pumped at a flow rate 0.25 ml/min and consisted
of 50 mM acetic acid, 0.25 M zinc acetate (pH 4.9) and 1.2% of ace-
tonitrile. Chromatography was carried out at 25°C. 
KYN was assessed according to the method described by
Holmes [15]. The chromatographic system Hewlett-Packard
(Germany) was composed of a HP 1050 series pump, Rheodyne
injection valve fitted with a sample loop (5 μl). A column –
LiChrospher 100 RP-18. 5 μm., 125 × 4 mm (Germany). Using 
a HP 1050 series UV detector (Germany) monitored the column
effluent (365 nm). The output of the detector was connected to 
a single instrument LC-2D ChemStation (Germany). The mobile
phase was pumped at a flow-rate of 1.5 ml/min. The mobile phase
consisted of 0.1 M. acetic acid, 0.1 M ammonium acetate (pH
4.65) containing 2% of acetonitrile. Chromatography was carried
out at 25°C.
3HKYN, 5HT and 5HIAA were assessed according to Heyes 
et al.  [16]. The reversed-phase HPLC system Hewlett-Packard
(Germany) was composed of a HP 1050 series pump, Rheodyne
injection valve fitted with a sample loop (5 μl). A column – S3
ODS2 150 × 2.1 mm was purchased from Waters-Spherisorb. The
column effluent was assessed using a programmable electro-
chemical detector HP 0149A (Germany), with the potential of
working electrode – 0.6 V. The output of the detector was con-
nected to a single instrument LC-2D ChemStation (Germany).
The mobile phase was pumped at a flow-rate of 0.25 ml/min. The
mobile phase consisted of 0.1 M triethylamine, 0.1 M phosphor-
ic acid, 0.3mM EDTA, 8.2 mM heptane-1-sulfonic acid sodium
salt, containing 2% of acetonitrile. Chromatography was carried
out at 25°C.
QUIN was measured using HPLC technique as described by
Werner-Felmayer et al. [17]. The chromatographic system
Hewlett-Packard (Germany) was composed of a HP 1050 series
pump, Rheodyne injection valve fitted with a sample loop (20
μl). Partisil 10 SAX 250 × 4.6 mm (Phase Separations, USA) co
umn was eluted with 50 mM potassium phosphate (pH 2.0) con-
taining 12% methanol at a flow rate of 2 ml/min. The amount of
2 ml of plasma was concentrated on Sep-Pack cartridges
(WATERS AccellTM Plus QMA), washed in 2 ml of water, and
eluted with 0.2 ml 4 M H3PO4 (recovery of spiked quinolinic acid
92%). Using a HP 1050 series UV detector  (Germany) the col-
umn effluent was monitored (272 nm). The output of the detector
was connected to a single instrument LC-2D ChemStation (Ger-
many). Chromatography was carried out at 25°C. 
Histological examination. A 3-5 mm3 portion of pancreas head
was fixed in 10% neutral formaldehyde solution and subsequently
embedded in paraffin. Sections were cut at  5 μm of thickness and
stained with hematoxylin and eosin. Assessment comprised edema,
inflammatory infiltration, fat necrosis, parenchymal necrosis and
hemorrhage.
Pancreatic edema. Pancreas water content was assessed by the tis-
sue wet/dry ratio. Pieces of pancreas were weighed immediately
after harvesting (wet weight) and again after desiccation (dry
weight). Desiccation was achieved in an oven at 120°C for 
24 hours.
Neurological evaluation. We adapted a simplified scheme of
Garcia et al. [13] (Table 2). Spontaneous activity of experimental
animals was observed for 5 min. in their normal environment (in 
a cage). 
Statistical analysis. All the groups were tested for normality.
Gaussian results were further evaluated using ANOVA, t-Student
and Pearson tests. Alternatively, non-parametric tests, such as:
Kruskal-Wallis, Mann-Whitney and Spearman's test were used to
assess population homogeneity, inter-group differences and corre-
lations between chosen metabolites, accordingly. The threshold of
significance was p<0.05.
Results
Histologic assessment (Fig. 2), amylase activity meas-
urement in plasma and wet/dry weight ratio (Table 1)
have confirmed the presence of necrotizing acute pan-
creatitis in studied animals. Marked increase in plasma
amylase activity was seen in the rats with necrotizing
acute pancreatitis, both 5 hours and 24 hours after the
onset of AP, as compared to the control group and to
sham-operated rats (Table 1). The increase exceeded 10-
fold in both cases. Sham operated animals did not differ
significantly from the control group, despite the cannu-
lation of biliopancreatic duct. Also the wet/dry ratio of
pancreata was substantially increased in animals with
experimental AP, both after 5 and 24 hours, as compared
to the control animals, as well as sham operated rats
(Table 1). The wet/dry ratio in the rodents was appar-
ently greater after sham operation than in not operated
animals, but no significant difference was found.
In animals with AP we observed a significant
reduction in neurological functions defined by applied
scoring system (Table 2), as compared to the control
(p<0.01) and sham-operated animals (p<0.05) (Table
1). We observed a transient impairment in neurological
function of rats 5 hours after sham-operation, Which
was no longer seen after 24 hours.
We observed substantial irregularities in TRP
metabolism during necrotizing acute pancreatitis in
rats. TRP (Table 3) showed a significant decrease after
24 hours from the onset of AP (p<0.05 as compared to
the control group and AP after 5 hours). In contrast to
TRP, we observed during AP early changes in  such
metabolites' levels as: KYN, 3HKYN, KYNA and
QUIN. The greatest increases were found in QUIN
concentration (21/2-fold, p<0.05); lesser for KYNA
(about 2-fold), 3HKYN and AA (about 11/2- fold).
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After 24 hours a drop could be observed in KYN
concentration in AP group (p<0.01 as compared to the
AP-5h group). Also other metabolites underwent nor-
malization after 24 hours: QUIN, KYNA, 3HKYN and
AA (p<0.001 for QUIN and AA as compared to AP-5
hours) (Table 3). 
Neither 5HT nor 5HIAA changed significantly
after induction of AP. In sham-operated animals 5HT
had lower values 5 hours after the operation than in the
control group (p<0.05). There was also a decrease in
QUIN level 5 hours after sham operation. 
There were no significant correlations between
plasma amylase activity or wet/dry ratio of pancreata
and any of the studied metabolites. However, using
Spearman's test, we found a high association between
neurological score and QUIN (p<0.05; R=0.918), as
assessed 5 hours after induction of AP. Similar corre-
lation was found for AA (p<0.05; R= 0.848).
Discussion
In the present study we demonstrated for the first time
an early increase in several TRP metabolites after
induction of experimental necrotizing AP. In descend-
ing order this was observed for: QUIN (21/2-fold) ,
KYNA (2-fold), KYN, AA and 3HKYN (11/2-fold).
Those changes were of short duration and after 24
hours were no longer observed. By that time, however,
a significant decrease in TRP was noted (by about 1/3).
This might suggest increased turnover of TRP via
kynurenine pathway in the early stage of AP. 
Acute pancreatitis triggers a cascade of cytokine
synthesis. The main molecules involved seem to be
interleukines (IL-1β, IL-6, IL-8) and TNF-α [18]. Also
a rise in interferon-γ (INF-γ) during AP has been
recently reported, especially in severe form of the dis-
ease [19]. INF-γ typically induces a depletion in TRP
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Table 3. Plasma concentrations of L-tryptophan (TRP), kynurenine (KYN), 3-hydroxykynurenine (3HKYN), kynurenic acid (KYNA),
anthranilic acid (AA), quinolinic acid, serotonin (5HT) and 5-hydroxyindolacetic acid (5HIAA) in plasma. Data represent the mean   SD
for AA and QA or median (full range) for the rest. Significant differences as compared to the control group are shown as: * – p<0.05; **
– p<0.01; as compared to sham operated animals: # – p<0.05; # # # – p<0.001; as compared to AP-5h: ^ – p<0.05; ^^ – p<0.01; ^^^ –
p<0.001. AP – acute pancreatitis.
Fig. 2. Histology of pancreata of rats with necrotizing acute pancreatitis: A – 5 hours after the induction of AP (H&E, original magnifi-
cation ×200); B – 24 hours after the induction of AP (H+E, original magnification ×200). 
and an increase in KYN, which in turn is further
metabolised to other compounds, including QUIN
(Fig. 1). There is evidence that INF-γ and TNF-α,
when present together, stimulate QUIN production
from TRP to levels exceeding neurotoxic threshold [8].
In this study we found an increase in KYN as assessed
5 hours after induction of the disease (Fig. 3). Interest-
ingly, TRP level decreased only after 24 hours after
induction of AP. Our results stand in favor for early
kynurenine pathway activation by IDO induction in
AP, although to obtain a direct evidence,  a measure-
ment of enzymes activity would be of value.
At least two of the above-mentioned TRP metabo-
lites have neurotoxic properties. This was first discov-
ered for QUIN, which caused seizures, when injected
to the brain of rodents [20]. Similar effects were
demonstrated by intravenous administration of QUIN
in rats with immature blood-brain barrier [10]. QUIN
is an endogenous agonist at the N-methyl-D-aspartate
sensitive subtype of glutamate receptors in the brain
[8]. It has also been suggested, that QUIN caused brain
damage via lipid peroxidation [21]. 
QUIN, when increased, has a potential of produc-
ing multiple organ impairment. The direct way leads to
excitotoxicity through N-methyl-D-aspartate (NMDA)
receptor activation in the nervous system. Additional-
ly, QUIN was reported to act via production of reactive
oxygen species [22]. QUIN provokes seizures when
injected into brain, but also after intravenous adminis-
tration when blood-brain barrier is not competent.
Under physiologic conditions in rats only 0.3% of
intravenously administered QUIN penetrates the blood
brain-barrier in a single passage, however, even then
brain concentration of QUIN may increase up to 10
times [8]. It has recently been shown that blood-brain
barrier permeability markedly increases in the early
course of AP [23]. It is also known that interferon-γ
activation increases local synthesis of QUIN in brain,
independently of changes in blood-brain barrier per-
meability [24]. Thus both increased blood-brain barri-
er permeability and enhanced local synthesis might
contribute to potential QUIN neurotoxicity in AP.
NMDA receptors activation does not explain all
QUIN actions. It has been established that QUIN
induces the formation of reactive oxygen species and
raises lipid peroxidation by up to 256% [8]. This might
aggravate the detrimental effect of free oxygen species
reported in AP [18]. Other actions of QUIN include
cardiac contractility impairment, probably by modula-
tion of heart calcium channel [25] and the inhibition of
erythropoiesis [26]. 
3HKYN is another potent neurotoxin, with recep-
tor-independent mode of action. It is one of most
potent known generators of reactive oxygen species
[27]. When injected into rat brain, 3HKYN caused tis-
sue damage around the injection site. QUIN needed 
4 times greater doses for the same effect [28]. More-
over, 3HKYN was reported to potentiate the neurotox-
icity of QUIN [29]. 
Another of TRP metabolites – KYNA is known for
its neuroprotective action and prevention of damage
induced by excess of QUIN [10]. Also KYN can play
a protective role against quinolinic acid-induced neu-
rotoxicity [30]. The addition of KYNA inhibited lipid
peroxidation induced by QUIN in brain tissue [21].
Similar properties were attributed to 5HT [9]. 
An intriguing question is why QUIN rises only
temporarily. One of possible explanations is the pas-
sage of QUIN outside blood vessels. The main com-
partment, where edema developes during AP is
abdominal cavity, especially peripancreatic space [31].
However, blood vessel wall permeability is markedly
increased also in brain during AP, as early as a few
hours after its onset [23]. This, however, is merely a
speculation and potential QUIN increase in the tissues
during AP needs further studies.
To sum up, we have found a transient, albeit
marked increase in plasma concentrations of several
TRP metabolites: QUIN, KYNA, KYN, AA, 3HKYN
in rats with experimental necrotizing AP. Despite short
duration of QUIN increase in blood, it might con-
tribute to neurological and possibly other organ distur-
bances during AP. This is supported by the association
between QUIN level in plasma and neurological
deficits in the animal model of taurocholate-induced
AP. Studies on tissue concentrations of QUIN and
other kynurenines during AP might bring new insights
into this intriguing problem.
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